CytoSorbents
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
305 College Rd E, Princeton, New Jersey,...Phone Number
(732) 329-8885Website
www.cytosorbents.comRevenue
$37.1 MillionStock Symbol
CTSOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
3
1
1
1
1
About CytoSorbents
CytoSorbents Corporation is engaged in the research, development, and commercialization of medical devices based on its blood purification technology platform, which utilizes proprietary adsorbent and porous polymer technology. The company operates in the United States, Germany, and internationally. Founded in 1997, CytoSorbents is headquartered in Princeton, New Jersey.Explore more
CytoSorbents Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CytoSorbents your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
CytoSorbents, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CytoSorbents is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at CytoSorbents
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CytoSorbents has new funding data
Website visits: Recent activity has been detected on your website
Check if CytoSorbents has recently received funding, and reach out quickly before it becomes old news!
Click to see if CytoSorbents had a recent Job posting/layoffs
Earning: See what the market has to say on CytoSorbents recently announced quarterly report
Product Launch: Get notified when CytoSorbents launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to CytoSorbents
Compare insights from companies similar to CytoSorbents, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CytoSorbents is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CytoSorbents is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CytoSorbents.
CytoSorbents financials insights
Gather financial insights about CytoSorbents, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$5M
2022
Debt
$5M
2025
Series A
$1.6M
CytoSorbents Tech Stack
A closer look at the technologies used by CytoSorbents
Most Recent Scoops
Hiring Plans
CytoSorbents has more open roles in Sales than it has had at any time in the past 12 months.
Hiring Plans
Person-Based
Forecasting, Business Finance, Finance
Person-Based
Earnings, Sales, Finance
Person-Based
Corporate Strategy, Finance, Risk
Person-Based
Business Finance, Clinical Operations, Finance
CytoSorbents News & Media
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31,...CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
PRINCETON, N.J., April 30, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2026 financial results and recent business...CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins Enhanced Balance Sheet Flexibility with an Additional $2.5 million Proceeds from Amended Credit Facility in November Implemented Strategic Workforce and Cost Reduction Program in Q4 to Accelerate Timing...CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
PRINCETON, N.J., March 19, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today announced three major developments at the International...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CytoSorbents
Sign Up For FreeTo access detailed company insights
CytoSorbents Corporation is engaged in the research, development, and commercialization of medical devices based on its blood purification technology platform, which utilizes proprietary adsorbent and porous polymer technology. The company operates in the United States, Germany, and internationally. Founded in 1997, CytoSorbents is headquartered in... Read More
